Breaking News Instant updates and real-time market news.

ALB

Albemarle

$67.87

0.31 (0.46%)

16:24
10/15/19
10/15
16:24
10/15/19
16:24

Albemarle initiated with a Market Perform at Wells Fargo

Wells Fargo analyst Michael Sison initiated coverage of Albemarle with a Market Perform rating and $75 price target. The analyst sees the company's growth slowing in 2020 due to limits on lithium capacity expansion and dilution from the MRL transaction. Investors will likely need a "distinct catalyst" to drive multiple expansion given the oversupply dynamic in the lithium industry, says Sison.

  • 07

    Nov

  • 19

    Nov

ALB Albemarle
$67.87

0.31 (0.46%)

08/14/19
VERF
08/14/19
NO CHANGE
VERF
Albemarle price target lowered to $39.80 from $58.50 at Vertical Group
Vertical Group analyst James Bardowski lowered his price target for Albemarle to $39.80 from $58.50 citing growth concerns following the company's decision to shelve ~47% of its previously planned lithium conversion capacity. The "abrupt change" in capacity plans away from "higher-value" lithium hydroxide will leave Albemarle "significantly more" levered to its spodumene mines in Australia, Bardowski told investors earlier in a research note. Further, the analyst points out that his work suggests spodumene is currently the most oversupplied segment of the lithium market. As such, he believes the company's decision implies lower future earnings potential. The analyst keeps a Sell rating on shares of Albemarle, whose stock is down 4% to $65.99 in early trading.
09/12/19
GABE
09/12/19
INITIATION
GABE
Buy
Albemarle initiated with a Buy at Gabelli
Gabelli analyst Joseph Catania started Albemarle with a Buy rating and 2020 private market value estimate of $109 per share. The company's Bromine and Catalysts businesses, by generating significant free cash, allow it fund the substantial capital expansion required to drive the growth of the lithium business, Catania tells investors in a research note. He believes Albemarle will turn free cash flow positive in 2021 and views the stock's current valuation as "compelling."
09/13/19
LOOP
09/13/19
NO CHANGE
Target $98
LOOP
Buy
Albemarle price target lowered to $98 from $100 at Loop Capital
Loop Capital analyst Chris Kapsch lowered his price target on Albemarle to $98 and also reduced his FY19 and FY20 EPS views by 7c and 65c to $6.38 and $6.25 respectively. The analyst notes that his broader lithium research report suggests that the company will not escape unscathed from the continued decline in spot lithium prices despite the pricing floors contained in its long-term supply agreements. Kapsch still keeps his Buy rating on Albemarle however, saying that he anticipates "meaningfully higher" production volume growth in 2021.
10/15/19
WELS
10/15/19
INITIATION
Target $75
WELS
Market Perform
Albemarle initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Michael Sison initiated coverage of Albemarle with a Market Perform rating and $75 price target.

TODAY'S FREE FLY STORIES

WBA

Walgreens Boots Alliance

$62.35

0.09 (0.14%)

10:46
11/12/19
11/12
10:46
11/12/19
10:46
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens Boots could be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 22

    Nov

QSR

Restaurant Brands

$67.39

-0.15 (-0.22%)

10:45
11/12/19
11/12
10:45
11/12/19
10:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

F

Ford

$9.11

0.03 (0.33%)

, GM

General Motors

$38.89

0.18 (0.46%)

10:38
11/12/19
11/12
10:38
11/12/19
10:38
Periodicals
Trump expected to extend deadline for EU car tariffs, Bloomberg says »

The Trump administration…

F

Ford

$9.11

0.03 (0.33%)

GM

General Motors

$38.89

0.18 (0.46%)

HMC

Honda

$29.35

0.15 (0.51%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$145.00

-0.07 (-0.05%)

TSLA

Tesla

$348.78

3.71 (1.08%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.21

0.1 (0.62%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 04

    Feb

KSS

Kohl's

$56.48

-0.56 (-0.98%)

10:35
11/12/19
11/12
10:35
11/12/19
10:35
Options
Kohl's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

10:35
11/12/19
11/12
10:35
11/12/19
10:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

DIS

Disney

$139.04

2.3 (1.68%)

10:31
11/12/19
11/12
10:31
11/12/19
10:31
Hot Stocks
Disney says Disney+ 'exceeded our high expectations,' working on glitches »

Disney+ Help tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$32.77

0.01 (0.03%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Options
Kraft Heinz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Roche to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

REPL

Replimune Group

$17.24

0.11 (0.64%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Replimune Group participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
UBS technology analysts to hold an analyst/industry conference call »

Technology Analysts…

LH

LabCorp

$165.45

-0.29 (-0.17%)

10:23
11/12/19
11/12
10:23
11/12/19
10:23
Syndicate
Breaking Syndicate news story on LabCorp »

LabCorp files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

, TEVA

Teva

$9.36

0.03 (0.32%)

10:21
11/12/19
11/12
10:21
11/12/19
10:21
On The Fly
JPMorgan gets less bearish on Xerox among today's top calls on Wall Street »

Check out today's top…

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

TEVA

Teva

$9.36

0.03 (0.32%)

AMRX

Amneal Pharmaceuticals

$2.69

0.05 (1.89%)

XRX

Xerox

$38.05

-0.28 (-0.73%)

HPQ

HP Inc.

$19.33

-0.31 (-1.58%)

AMAT

Applied Materials

$56.81

0.21 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 26

    Nov

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

UCBJY

UCB

$0.00

(0.00%)

10:20
11/12/19
11/12
10:20
11/12/19
10:20
Conference/Events
UCB participates in a conference call with JPMorgan »

European Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$19.92

3.02 (17.87%)

10:18
11/12/19
11/12
10:18
11/12/19
10:18
On The Fly
Analysts see good odds of Amarin's Vascepa label expansion after docs posted »

Stifel analyst Derek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/12/19
11/12
10:17
11/12/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

, CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

STOK

Stoke Therapeutics

$30.87

1.04 (3.49%)

BMRN

BioMarin

$75.96

0.72 (0.96%)

BIIB

Biogen

$291.50

-2.41 (-0.82%)

AMGN

Amgen

$223.35

2.66 (1.21%)

CTVA

Corteva

$27.06

0.32 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

  • 09

    Dec

CSX

CSX

$72.89

-1.04 (-1.41%)

, ETN

Eaton

$91.78

-0.09 (-0.10%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CSX

CSX

$72.89

-1.04 (-1.41%)

ETN

Eaton

$91.78

-0.09 (-0.10%)

AMRX

Amneal Pharmaceuticals

$2.71

0.07 (2.65%)

ALB

Albemarle

$67.47

-0.25 (-0.37%)

BOX

Box

$15.93

-0.52 (-3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 26

    Nov

  • 12

    Dec

ARGO

Argo Group

$63.82

2.54 (4.14%)

, LYV

Live Nation

$64.79

0.32 (0.50%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

ARGO

Argo Group

$63.82

2.54 (4.14%)

LYV

Live Nation

$64.79

0.32 (0.50%)

RCII

Rent-A-Center

$23.13

0.78 (3.49%)

CRWD

Crowdstrike

$47.25

1.07 (2.32%)

TEVA

Teva

$9.40

0.07 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$138.17

1.43 (1.05%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Periodicals
Disney tells CNBC streaming service launch exceeds 'high expectations' »

CNBC reported via Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.90

-0.01 (-0.17%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

IDRA

Idera Pharmaceuticals

$2.29

0.06 (2.69%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Conference/Events
Idera Pharmaceuticals participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$138.25

1.51 (1.10%)

10:12
11/12/19
11/12
10:12
11/12/19
10:12
Periodicals
Disney working to fix Disney+ issues amid 'incredible response,' TechCrunch says »

Disney+ users have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.